Fidelity Disruptive Medicine ETF (FMED) To Go Ex-Dividend on December 20th

Fidelity Disruptive Medicine ETF (NASDAQ:FMED) declared a quarterly dividend on Friday, December 20th,NASDAQ Dividends reports. Investors of record on Friday, December 20th will be paid a dividend of 0.112 per share on Tuesday, December 24th. This represents a $0.45 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date of this dividend is Friday, December 20th. This is a positive change from Fidelity Disruptive Medicine ETF’s previous quarterly dividend of $0.001.

Fidelity Disruptive Medicine ETF Stock Performance

Shares of NASDAQ FMED opened at $25.03 on Friday. The stock has a market cap of $52.56 million, a PE ratio of 35.73 and a beta of 0.94. Fidelity Disruptive Medicine ETF has a 52-week low of $23.22 and a 52-week high of $26.68. The business has a fifty day moving average of $25.84 and a two-hundred day moving average of $25.32.

Fidelity Disruptive Medicine ETF Company Profile

The Fidelity Disruptive Medicine ETF (FMED) is an exchange-traded fund that mostly invests in health care equity. The fund is an actively managed fund that invests in companies involved in disruptive innovation in Health Care. The fund invests in securities of domestic and foreign issuers FMED was launched on Apr 16, 2020 and is managed by Fidelity.